Immunosign® for Clinical Research is a suite of gene expression assays applicable to most cancer types and stages for clinical investigations.
- Robust gene expression assays
- Selection of key immune genes
- Proprietary algorithm for unsurpassed results
Easy customization to include your biomarker of interest.
All assays are amenable to clinical trial assays and companion diagnostics.